E7070 in Treating Patients With Stage IV Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

November 30, 2001

Conditions
Melanoma (Skin)
Interventions
DRUG

indisulam

Trial Locations (12)

1000

Institut Jules Bordet, Brussels

1093

Instituto Portugues de Oncologia de Francisco Gentil, Lisbon

35064

Centre Eugene Marquis, Rennes

63011

Centre Jean Perrin, Clermont-Ferrand

69373

Centre Leon Berard, Lyon

80131

Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples

A-1100

Kaiser Franz Josef Hospital, Vienna

D-30625

Medizinische Hochschule Hannover, Hanover

N-0310

Norwegian Radium Hospital, Oslo

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

SW3 6JJ

Royal Marsden NHS Trust, London

EH4 2XU

Western General Hospital, Edinburgh

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00014625 - E7070 in Treating Patients With Stage IV Melanoma | Biotech Hunter | Biotech Hunter